The patients who will enroll in your peptide program are already on your schedule. They trust you, they have asked about GLP-1s or recovery or energy or skin, and reaching them costs nothing beyond a conversation and a handout. Marketing a peptide program to existing patients is an education job, not an advertising job: tell them the program exists, explain what it is and who it is for, offer a low-commitment way to try it, and follow up. Do that at five touchpoints inside the practice and on one page of the website, and the program fills without paid ads and without a single claim you cannot back up.
Why start with existing patients instead of advertising?
Three reasons. First, trust. A patient who has been coming to you for two years does not need to be convinced that you are a credible source. A stranger on social media does. Second, intent. Patients who have been on a GLP-1, who are recovering from a procedure, or who ask about energy and aging at every visit have already told you which category they belong in. Third, cost. There is no ad spend, no landing page, and no lead form between you and a patient who is sitting in the exam room.
The revenue model makes the case on its own. As How Practices Build a Six-Figure Peptide Revenue Line lays out, the revenue engine is the monthly reorder, not the first sale. Reorders come from patients who are supervised, followed up, and seen regularly. That describes your existing patient base, not a cold lead.
What can a practice say about peptides without making a claim?
The rule is one sentence: describe what the program is, never what it will do for the patient. Everything else follows from that.
Say this. The product category and its regulatory status in plain words. The delivery format, which for the AgeREcode formulated line is enteric-coated oral capsules and topical serums, with no injections. That the program is supervised by a licensed provider with a set follow-up schedule. What the program includes: a consult, a protocol, check-ins, and a 90-day review. That a one-week sample is available.
Not this. That the product treats, cures, or prevents any condition. That it is FDA-approved when it is not. Before-and-after photos or testimonials that imply a result the next patient should expect. Guarantees, timelines, or percentages. Comparisons to prescription drugs that imply equivalence.
The Federal Trade Commission's Health Products Compliance Guidance is the reference for the marketing side, and its position on testimonials is the one to remember: a testimonial cannot make a claim the advertiser could not make and substantiate directly. For what each regulatory lane permits, see the three regulatory lanes for peptides. The useful finding is that compliant language and effective language are the same language. Patients respond to "supervised, needle-free, and you can try it for a week" more than they respond to a promise, because a promise from a clinic sounds like an ad.
What are the five touchpoints inside the practice?
| Touchpoint | What happens | Who owns it | What to measure |
|---|---|---|---|
| Intake form | One added question: "Would you like information about our supervised peptide program?" with the five categories as checkboxes | Front desk | Asks per week |
| Exam room | Provider mentions the program when the patient raises a matching concern, hands over the one-page handout, and offers a consult | Provider | Consults booked |
| Checkout | Front desk confirms the consult, or offers the handout and sample pack information to patients who checked the box | Front desk | Sample packs dispensed |
| Segmented email or text | One message per segment: current and former GLP-1 patients, post-procedure patients, aesthetics patients, longevity patients | Office manager | Replies and consults booked |
| In-office materials | A counter card at checkout, the handout in each exam room, one slide in the waiting-room loop | Office manager | Patient questions prompted |
Two notes on the table. The intake question is the highest-yield item on the list because it makes the patient raise the topic, which is more comfortable for the provider than bringing it up unprompted. And the email segments map directly to the five patient-facing categories described in GLP-1s Are Just the Beginning, so one message per category speaks to a real concern rather than announcing a generic product.
Ready to add peptides to your practice?
Apply for wholesale access to pricing, protocols, and sample kits.
What should the website page say?
One page, linked from the main navigation, written for a patient who heard about the program at a visit and went home to look it up. It needs six parts:
- What the program is. A supervised peptide program, in two or three sentences, using the same language as the handout.
- Who it is for. The five categories, each as a short paragraph describing the patient concern, not the outcome. Metabolic support alongside or after a GLP-1. Recovery after a procedure or training. Cognitive focus. Energy and healthy aging. Skin and cosmetic.
- How it works. Consult, protocol, two-week check-in, progress review, 90-day review. The same schedule the clinical team uses.
- The format. Needle-free: enteric-coated oral capsules and topical serums. This line does more work than any other on the page, because it answers the objection most patients have before they ask.
- How to start. A consult booking button and the sample pack offer.
- The disclaimer and regulatory status. Written in plain words, placed where a reader will see it, matching the consent form.
Leave out pricing, before-and-after imagery, and testimonials. Add a short FAQ with the questions your front desk hears most often, which gives the page a chance to rank for the questions patients search.
How does the sample pack turn interest into a protocol?
A one-week sample does three things an explanation cannot. It makes the commitment small: "take one capsule a day for a week" is a decision a patient can make at the counter. It converts the abstract into the physical: the patient leaves with something in hand. And it creates the follow-up: the sample runs out in seven days, which is the natural moment for the two-week check-in call and the protocol conversation.
Offer the sample at the consult, not before it. The consult is where the provider confirms the patient is a fit, collects the baseline, and signs the consent. The sample is the output of that visit. A sample handed over without a consult skips the supervision that makes the program a program, and it produces a patient with no scheduled follow-up, which is a patient who does not reorder.
What should staff say?
Every staff member who talks to patients needs the same three sentences, in their own words:
- "We offer a supervised peptide program for patients interested in metabolic support, recovery, focus, energy, or skin."
- "The products are oral capsules and topical serums, so there are no injections, and a provider follows you through the program with scheduled check-ins."
- "If you would like to learn more, I can book a consult, and there is a one-week sample you can try after that."
Then the question every patient asks, with its answer: "Is this FDA-approved?" "Some peptides are FDA-approved prescription drugs. The products in our program are a different regulatory category, and the provider will walk you through what that means at the consult." Staff who have that answer ready sound credible. Staff who do not have it ready sound like they are hiding something.
Which five numbers tell you whether it is working?
Asks, consults, trials, protocols, and reorders. Count them weekly on one line in a spreadsheet.
- Asks are patients who checked the intake box, replied to an email, or asked a staff member. If asks are low, the touchpoints are not visible enough.
- Consults are booked visits. If asks are high and consults are low, the staff script or the booking step needs work.
- Trials are sample packs dispensed after a consult. If consults are high and trials are low, the provider conversation needs work.
- Protocols are patients who moved from the sample to a full protocol. If trials are high and protocols are low, the two-week follow-up call is not happening.
- Reorders are monthly. If protocols are high and reorders are low, the follow-up cadence is breaking down after the first month.
Each gap points to one fix. That is the advantage of a five-step funnel over a single revenue number.
How does AgeREcode support the marketing side?
The Clinical Operator's Manual includes patient education materials and marketing guidance written for the regulatory lane the products occupy, so the handout, the website copy, and the consent form all say the same thing. The Peptide Protocol Portal carries patient handouts and a video library staff can use for training on the three-sentence script. Sample packs are part of the wholesale catalog, which is what makes the trial step possible. And the formulated line is needle-free, which is the single most useful sentence any practice can put in front of a patient. Pricing guides and program-structure examples are provided to wholesale partners after approval.
The practices that fill a peptide program are not the ones with the biggest ad budget. They are the ones where every patient who had a matching concern heard about the program, from someone they already trusted, and left with a way to try it.
Frequently Asked Questions
Can a medical practice or med spa advertise peptides?
Yes, within the rules of the regulatory lane the products occupy and your state's rules on medical advertising. Describe the category, the format, and the supervision. Do not claim that a product treats, cures, or prevents a condition, do not call an unapproved product FDA-approved, and do not use testimonials or before-and-after imagery that imply a result the next patient should expect. Review your materials with counsel familiar with your state.
Can I use patient testimonials for a peptide program?
Treat testimonials with caution. Under FTC guidance a testimonial cannot make a claim the practice could not make and substantiate directly, and "results not typical" does not fix a claim that overstates what a typical patient should expect. Most practices are better served by describing the program than by quoting a patient.
How do I introduce peptides to my GLP-1 patients?
Add the intake question, and raise the program when the patient asks about appetite, plateaus, maintenance after a GLP-1, or what comes next. Describe the metabolic category and the oral format, offer a consult, and let the provider cover the rest. Current and former GLP-1 patients are the single largest segment of existing patients who have already shown interest.
What should a peptide program page on my website include?
What the program is, who it is for by category, how it works, the needle-free format, how to start, and the regulatory disclaimer. Leave out pricing, before-and-after photos, and testimonials. Add a short FAQ made of the questions your front desk hears most often.
Do I need paid ads to fill a peptide program?
Not to start. Most practices fill the first 90 days from existing patients through the five in-practice touchpoints. Paid ads come later, if at all, and face platform restrictions on health claims that make compliant copy harder to run. Fill the program from the schedule first.
This article provides general information about practice marketing, not legal advice. Advertising and medical-practice rules vary by state. Review your materials with counsel familiar with your state's medical board and advertising regulations. Statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. For licensed providers only.
